Evidence map›Paper›PMID 42222134›Full record

ArticleLearning with longitudinal medical images and data : first International Workshop, LMID 2025, held in conjunction with MICCAI 2025, Daejeon, South Korea, September 27, 2025, Proceedings. International Workshop on Learning with Longitudi...2026

Two-Stage Decoupling Framework for Variable-Length Glaucoma Prognosis.

Yiran Song, Yikai Zhang, Silvia Orengo-Nania, Nian Wang, Fenglong Ma, Rui Zhang, Yifan Peng, Mingquan Lin

Abstract read
In one paragraph

Article in Learning with longitudinal medical images and data : first International Workshop, LMID 2025, held in conjunction with MICCAI 2025, Daejeon, South Korea, September 27, 2025, Proceedings. International Workshop on Learning with Longitudi..., 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yiran SongUniversity of Minnesota, Minneapolis MN, USA.
Yikai ZhangUniversity of Minnesota, Minneapolis MN, USA.
Silvia Orengo-NaniaUniversity of Minnesota, Minneapolis MN, USA.
Nian WangUT Southwestern Medical Center, Dallas TX, USA.
Fenglong MaThe Pennsylvania State University, University Park PA, USA.
Rui ZhangUniversity of Minnesota, Minneapolis MN, USA.
Yifan PengWeill Cornell Medicine, New York NY, USA.
Mingquan LinUniversity of Minnesota, Minneapolis MN, USA.

Funding

Achieving Model Fairness on Automatic Primary Open-angle Glaucoma ScreeningR21EY035296 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI PENG, YIFAN · 2023 to 2023
$466k
NEI NIH HHS R21 EY035296
6 · The paper itself

Abstract

Glaucoma is one of the leading causes of irreversible blindness worldwide. Glaucoma prognosis is essential for identifying at-risk patients and enabling timely intervention to prevent blindness. Many existing approaches rely on historical sequential data but are constrained by fixed-length inputs, limiting their flexibility. Additionally, traditional glaucoma prognosis methods often employ end-to-end models, which struggle with the limited size of glaucoma datasets. To address these challenges, we propose a Two-Stage Decoupling Framework (TSDF) for variable-length glaucoma prognosis. In the first stage, we employ a feature representation module that leverages self-supervised learning to aggregate multiple glaucoma datasets for training, disregarding differences in their supervisory information. This approach enables datasets of varying sizes to learn better feature representations. In the second stage, we introduce a temporal aggregation module that incorporates an attention-based mechanism to process sequential inputs of varying lengths, ensuring flexible and efficient utilization of all available data. This design significantly enhances model performance while maintaining a compact parameter size. Extensive experiments on two benchmark glaucoma datasets-the Ocular Hypertension Treatment Study (OHTS) and the Glaucoma Real-world Appraisal Progression Ensemble (GRAPE), which differ significantly in scale and clinical settings, demonstrate the effectiveness and robustness of our approach. Code is available: MICCAI LMID Repository.

Indexed as

Attention-Based Temporal AggregationGlaucoma PrognosisSelf-Supervised LearningVariable-length Sequences

Identifiers

PMID42222134
PMCPMC13222103

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.